Your browser doesn't support javascript.
loading
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis.
Dohrn, Maike F; Ihne, Sandra; Hegenbart, Ute; Medina, Jessica; Züchner, Stephan L; Coelho, Teresa; Hahn, Katrin.
Affiliation
  • Dohrn MF; Department of Neurology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Ihne S; Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, FL, USA.
  • Hegenbart U; Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital of Würzburg, Würzburg, Germany.
  • Medina J; Department of Internal Medicine II, Hematology, University Hospital Würzburg, Würzburg, Germany.
  • Züchner SL; Comprehensive Heart Failure Center (CHFC), University and University Hospital Würzburg, Würzburg, Germany.
  • Coelho T; Amyloidosis Center Heidelberg, Department of Internal Medicine V, Division of Hematology/Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hahn K; Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, FL, USA.
J Neurochem ; 156(6): 802-818, 2021 03.
Article in En | MEDLINE | ID: mdl-33155274
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prealbumin / Amyloidosis, Familial Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Animals / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prealbumin / Amyloidosis, Familial Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Animals / Humans Language: En Year: 2021 Type: Article